Literature DB >> 1646284

Role of viral ribonucleotide reductase in the increase of dTTP pool size in herpes simplex virus-infected Vero cells.

T Daikoku1, N Yamamoto, K Maeno, Y Nishiyama.   

Abstract

Infection of Vero cells with herpes simplex virus (HSV) causes a marked increase in the dTTP pool size of infected cells. In this study we examined the relative importance of the HSV-encoded ribonucleotide reductase (RR) and thymidine kinase (TK) in the increase of dTTP. In cells infected with an RR deletion mutant of HSV-1 strain KOS, there was no significant increase in the size of the dTTP pool, whereas the dTTP pool in HSV-1(TK-)-infected cells was increased in size to almost the same extent as that in HSV-1(TK+)-infected cells. Moreover, it was found that the increase in dTTP pool size was strongly inhibited by the addition of hydroxyurea, a specific inhibitor of RR, and 5-fluoro-2'-deoxyuridine, a specific inhibitor of thymidylate synthetase. These results suggest that the induction of viral RR is of primary importance in the increase of dTTP pool size in HSV-1-infected Vero cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646284     DOI: 10.1099/0022-1317-72-6-1441

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency.

Authors:  R B Pyles; N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Stimulation of thymidine kinase activity in baculovirus infected cells is not due to a virus-coded enzyme.

Authors:  X Wang; W Xie; Q Long; D He; G Lin; Y Pang; Z Pu
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.

Authors:  K D Croen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

4.  Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.

Authors:  Y Kulu; H Kawasaki; J M Donahue; H Kasuya; J C Cusack; E W Choi; D K Kuruppu; B C Fuchs; K K Tanabe
Journal:  Cancer Gene Ther       Date:  2013-01-25       Impact factor: 5.987

5.  Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit.

Authors:  A Marcello; A Loregian; A Cross; H Marsden; T R Hirst; G Palù
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.

Authors:  Livia Vastag; Emre Koyuncu; Sarah L Grady; Thomas E Shenk; Joshua D Rabinowitz
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

Review 7.  The molecular biology of frog virus 3 and other iridoviruses infecting cold-blooded vertebrates.

Authors:  V Gregory Chinchar; Kwang H Yu; James K Jancovich
Journal:  Viruses       Date:  2011-10-20       Impact factor: 5.048

8.  Accelerated Metabolite Levels of Aerobic Glycolysis and the Pentose Phosphate Pathway Are Required for Efficient Replication of Infectious Spleen and Kidney Necrosis Virus in Chinese Perch Brain Cells.

Authors:  Xixi Guo; Shiwei Wu; Ningqiu Li; Qiang Lin; Lihui Liu; Hongru Liang; Yinjie Niu; Zhibin Huang; Xiaozhe Fu
Journal:  Biomolecules       Date:  2019-09-02

9.  Mutations in accessory DNA replicating functions alter the relative mutation frequency of herpes simplex virus type 1 strains in cultured murine cells.

Authors:  R B Pyles; R L Thompson
Journal:  J Virol       Date:  1994-07       Impact factor: 6.549

10.  An invertebrate Warburg effect: a shrimp virus achieves successful replication by altering the host metabolome via the PI3K-Akt-mTOR pathway.

Authors:  Mei-An Su; Yun-Tzu Huang; I-Tung Chen; Der-Yen Lee; Yun-Chieh Hsieh; Chun-Yuan Li; Tze Hann Ng; Suh-Yuen Liang; Shu-Yu Lin; Shiao-Wei Huang; Yi-An Chiang; Hon-Tsen Yu; Kay-Hooi Khoo; Geen-Dong Chang; Chu-Fang Lo; Han-Ching Wang
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.